Latest 10-K annual reports

OTC.Pink
PAID Inc. announces a net income of $763,592 for 2024, primarily driven by growth in its shipping coordination and label generation services.
Abpro Holdings' 10-K filing reveals a restatement of prior financials due to accounting errors, raising concerns about the company's ability to continue as a going concern and impacting investor confidence.
OQB
CERo Therapeutics' 2024 10-K filing reveals ongoing losses, clinical trial advancements, and substantial doubt about its ability to continue as a going concern.
Bukit Jalil Global Acquisition 1 Ltd. reports its 2024 financial results in a Form 10-K filing, highlighting a proposed business combination with GIBO and ongoing concerns about its ability to continue as a going concern.
OID
Saker Aviation Services reports a decrease in net income for FY 2024 and the termination of its Downtown Manhattan Heliport concession agreement, prompting a search for alternative revenue streams.
NASDAQ
Greenwich LifeSciences focuses on its Phase III clinical trial, Flamingo-01, evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, while reporting a net loss of $15.8 million for 2024.
BioSig Technologies reports its annual results on Form 10-K, highlighting ongoing efforts to regain Nasdaq compliance amidst financial challenges and a potential delisting.
NASDAQ
OneMedNet Corporation reports a net loss of $10.1 million for 2024 and expresses substantial doubt about its ability to continue as a going concern.
NASDAQ
Borealis Foods Inc.'s 2024 10-K filing reveals a strategic shift towards higher-margin products amidst financial uncertainties and a going concern warning.
AMEX
WidePoint Corporation's 2024 10-K filing reveals a significant revenue increase driven by carrier and managed services, but also highlights ongoing concerns about contract renewals and internal control weaknesses.
NASDAQ
Clean Energy Technologies, Inc. files an amendment to its 2024 annual report to include the company's newly adopted clawback policy.
NASDAQ
ABVC BioPharma reports increased revenue for fiscal year 2024, but faces ongoing financial challenges and a restatement of prior year financials.
NASDAQ
Rent the Runway's FY24 results show modest revenue growth and a strategic shift towards enhanced customer experience and cost efficiency for FY25.
OID
Ozop Energy Solutions' 2024 annual report reveals increased net losses, a working capital deficit, and substantial doubt about the company's ability to continue as a going concern.
NASDAQ
Greenwave Technology Solutions reports a decrease in revenue for fiscal year 2024, alongside increased operating expenses and net losses, while addressing going concern uncertainties and Nasdaq compliance.
NASDAQ
Eightco Holdings Inc.'s 2024 annual report reveals a strategic shift towards inventory financing and digital media, alongside the sale of its Corrugated Packaging Business, with mixed financial outcomes.
AlphaTime Acquisition Corp reports a net income of $1,498,591 for the year ended December 31, 2024, while actively pursuing a business combination.
NASDAQ
Future FinTech Group Inc. details its financial performance for the year ended December 31, 2024, highlighting a shift in business focus and addressing ongoing legal and regulatory hurdles.
OID
Transportation and Logistics Systems, Inc. reports a net loss of $3.82 million for 2024 and expresses substantial doubt about its ability to continue as a going concern in its latest 10-K filing.
Beeline Holdings, formerly Eastside Distilling, reports its 10-K filing, highlighting a year of strategic transformation marked by the acquisition of Beeline Financial, the sale of its craft business, and a shift in focus towards fintech mortgage lending and spirits distribution.
NASDAQ
Algorhythm Holdings, an AI technology and consumer electronics holding company, reports a net loss for 2024, impacted by non-cash charges and strategic business developments.
Wenyuan Group Corp. reports a significant increase in revenue for 2024 driven by cultural and health product sales, while discontinuing its aquaculture business.
OTC.Pink
Forge Innovation Development Corp.'s 2024 10-K filing reveals a revenue increase driven by the Legend LP acquisition, but also highlights substantial doubt about the company's ability to continue as a going concern due to recurring losses and negative cash flow.
NASDAQ
ZW Data Action Technologies Inc. reports a decrease in revenue for fiscal year 2024 due to a strategic repositioning, focusing on higher-margin digital advertising opportunities.
ONAR Holding Corporation's 10-K filing reveals a strategic focus on marketing technology amid financial concerns and internal control weaknesses.
OID
Charging Robotics Inc. files its annual report on Form 10-K, detailing its financial performance and strategic focus on wireless charging systems for electric vehicles, particularly in robotic parking systems.
AMEX
Milestone Scientific's 2024 10-K filing reveals a decrease in revenue, continued operating losses, and efforts to secure additional funding while expanding its medical product line and distribution.
NASDAQ
OLB Group's 2024 annual report reveals a substantial revenue decrease and a net loss, highlighting challenges in its core business segments and ongoing efforts to spin off its Bitcoin mining operations.
OTC.Pink
Mosaic ImmunoEngineering's 10-K filing reveals substantial doubt about its ability to continue as a going concern, despite efforts to acquire new technologies from Oncotelic Therapeutics.
NASDAQ
Jaguar Health amends its annual report to include previously omitted information regarding directors, executive officers, and corporate governance.